You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 6, June 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Management of Extranodal Head and Neck Lymphomas

Charlotte Jacobs, MD; Lawrence Weiss, MD; Richard T. Hoppe, MD

Arch Otolaryngol Head Neck Surg. 1986;112(6):654-658.


Abstract

• The results from 156 patients with extranodal head and neck lymphomas treated at Stanford (Calif) University School of Medicine are combined with the experience of other investigators to recommend the management of these lymphomas. The tonsil and sinuses were the most common sites of presentation, and the most common histology was diffuse histiocytic lymphoma. The histologic classification systems are described as well as the use of immunohistochemistry in diagnosis. The appropriate staging procedures and the Ann Arbor staging system are discussed. Following the staging of 948 patients, 66% were found to have stage I or stage II disease and 34% had more widespread disease. Treatment with radiotherapy is discussed. Patterns of relapse following local radiotherapy for 360 relapsing patients with stage I and II disease showed a 73% distal relapse rate. Various treatment programs are recommended based on site, stage, and histology.

(Arch Otolaryngol Head Neck Surg 1986;112:654-658)



Author Affiliations

From the Department of Medicine, Division of Oncology (Dr Jacobs), the Department of Pathology (Dr Weiss), and the Department of Radiation Therapy (Dr Hoppe), Stanford (Calif) University School of Medicine.


Footnotes

Accepted for publication Oct 25, 1985.

Reprint requests to Division of Oncology, M-211, Stanford University School of Medicine, Stanford, CA 94305 (Dr Jacobs).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of Rituximab in Combination with Conventional Chemotherapy for the Treatment of Non-Hodgkin's Lymphoma of the Head and Neck
MANOLOPOULOS et al.
In Vivo 2009;23:475-478.
ABSTRACT | FULL TEXT  

Primary Malignant Lymphoma of the Parotid Gland
Barnes et al.
Arch Otolaryngol Head Neck Surg 1998;124:573-577.
ABSTRACT | FULL TEXT  

Extranodal Lymphomas of the Head and Neck: A 20-Year Experience
Hanna et al.
Arch Otolaryngol Head Neck Surg 1997;123:1318-1323.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.